Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartBeam (BEAT) Capital Expenditures (2023 - 2026)

HeartBeam (BEAT) reported Capital Expenditures of $114000.0 for Q1 2026, up 5600.0% year-over-year from $2000.0 in Q1 2025, and down 72.6% on a QoQ basis from $416000.0 in Q4 2025.

HeartBeam (BEAT) has 4 years of Capital Expenditures data on file, last reported at $114000.0 in Q1 2026.

  • Quarterly Capital Expenditures rose 5600.0% year-over-year to $114000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $712000.0 (up 250.74% YoY) and the FY2025 annual result came in at $600000.0, up 198.51% from the prior year.
  • Capital Expenditures eased to $114000.0 in Q1 2026 per BEAT's latest filing, from $416000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $416000.0 in Q4 2025 and bottomed at $2000.0 in Q1 2025.
  • The 4-year median for Capital Expenditures is $114000.0 (2026), against an average of $130111.1.
  • The widest annual swing landed in 2025, when Capital Expenditures slipped 15.14%; it then soared 5600.0% in 2026.
  • Tracing BEAT's Capital Expenditures over 4 years: stood at $112000.0 in 2023, then surged by 65.18% to $185000.0 in 2024, then jumped by 124.86% to $416000.0 in 2025, then plunged by 72.6% to $114000.0 in 2026.
  • Per Business Quant, the three latest BEAT Capital Expenditures figures stand at $114000.0 (Q1 2026), $416000.0 (Q4 2025), and $157000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 7.03 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 3.67 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 15.93 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 28,000.00
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 2.25 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 15.33 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 118,000.00
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 12.44 Mn
10 HeartBeam 5.16 Mn 5.16 Mn - 114,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 114,000.00
Mar 31, 2026 114,000.00
Dec 31, 2025 416,000.00
Dec 31, 2025 416,000.00
Sep 30, 2025 157,000.00
Sep 30, 2025 157,000.00
Jun 30, 2025 25,000.00
Jun 30, 2025 25,000.00
Mar 31, 2025 2,000.00
Mar 31, 2025 2,000.00
Sep 30, 2024 185,000.00
Sep 30, 2024 185,000.00
Jun 30, 2024 16,000.00
Jun 30, 2024 16,000.00
Dec 31, 2023 112,000.00
Dec 31, 2023 112,000.00
Sep 30, 2023 144,000.00
Sep 30, 2023 144,000.00